People · Operator
Named in public records as an officer, director or promoter · active 2010–2016 · Biotech / Pharma, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ClearLight Biotechnologies, LLC | — | Biotech / Pharma | Seed | $8.8M | $113.9M | 2015 |
| Pinnacle Care International Inc | — | Other Health Care | Series A | $8.2M | $165.0M | 2010 |
John Snyder at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Snyder on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Collins | 1 | 5 |
| Albert Hansen | 1 | 3 |
| Joseph Gorman | 1 | 2 |
| Laurie Goodman | 1 | 1 |
| Miles Varn | 1 | 1 |
| Bruce Spector | 1 | 1 |
| William Kiser | 1 | 1 |
| Robert Schuler | 1 | 1 |
| Josephine Linden | 1 | 1 |
| Leslie Bider | 1 | 1 |
| Barry Bloom | 1 | 1 |
| Richard Rossi | 1 | 1 |
| Sarah McCurdy | 1 | 1 |
| John Hutchins | 1 | 1 |
| Alex Wiegers | 1 | 1 |
| Karl Deisseroth | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.